^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Childhood B Acute Lymphoblastic Leukemia |
| Drug: | cyclophosphamide (Alkylating agent) + etoposide oral (Topoisomerase II inhibitor, DNA inhibitor) + nelarabine (DNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Pediatric Acute Lymphoblastic Leukemia: Other Recommended regimens…Nelarabine-containing regimens: eg, nelarabine, cyclophosphamide, and etoposide
